Connecticut launches first state-funded methadone vans
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The APT Foundation launched two state-funded mobile methadone units in July 2025 serving Greater New Haven and the southeastern shoreline, while Community Health Resources (CHR) will begin its northeastern Connecticut route on Aug. 18, 2025 — the first state-funded mobile methadone units in Connecticut history.
- Connecticut invested more than $4 million drawn from opioid settlement funds into the vans, part of a larger $185 million settlement pot with 22% earmarked for treatment access.
- The northeastern "Quiet Corner" region has only three methadone clinics for mostly rural towns under 10,000 people, and Windham County reported 62.9 unintentional drug overdose deaths per 100,000 in 2024 — the seventh-highest rate in the state and four times the national average.
- Methadone is the most tightly regulated of three FDA-approved opioid use disorder medications, requiring in-person clinic visits rather than a pharmacy pickup, and some eastern Connecticut residents on public transit spend up to three hours one-way to reach the nearest clinic.
- Recovery support specialist Frankie DeJesus drove 30 minutes from Enfield to Hartford's Root Center every day for a year and a half starting in 2012, describing the trip — sometimes involving the HOV lane or missed doses — as "a huge barrier to my recovery."
- Federal regulators cleared the path for expansion: the DEA lifted its 2007 ban on new mobile methadone units in 2021, and at least 17 states have since launched mobile programs, building on a model that began in Amsterdam in 1979 and in Brockton, Mass. in 1988.
Why it matters: For opioid use disorder patients in rural Connecticut, geography and transit gaps had made daily methadone treatment nearly impossible — some faced three-hour one-way bus rides. The vans specifically target Windham County, where overdose deaths run four times the national average, meaning the mobile units are reaching the population with the highest mortality and the fewest clinic options. With $185 million in opioid settlement funds, 22% committed to treatment access, Connecticut is now using that windfall to dismantle what researchers call a decades-old regulatory bottleneck on the most effective medication for opioid addiction.
Ask SkimNews
